Reply to "Targeting cholesterol homeostasis through inhibiting: An Achilles' heel for glioblastoma?"

Neuro Oncol. 2023 Nov 2;25(11):2103-2104. doi: 10.1093/neuonc/noad146.

Danling Gu^{1

2}, Hao You^{1

2}, Jiancheng Gao^{1

2

3}, Yongping You^{2

3}, Jeremy N Rich^{4

5}, Junxia Zhang^{2

3}, Xiuxing Wang^{1

2

6}

¹ National Health Commission Key Laboratory of Antibody Techniques, Department of Cell Biology, Jiangsu Provincial Key Laboratory of Human Functional Genomics, School of Basic Medical Sciences, Nanjing Medical University, Jiangsu, China.
² Institute for Brain Tumors, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Jiangsu, China.
³ Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University, Jiangsu, China.
⁴ University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.
⁵ Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
⁶ Jiangsu Cancer Hospital, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu, China.

No abstract available

MeSH terms